The grant will enable Bio-CapnoMAD to pursue development and prepare for clinical trials.
Company Description
Bio-CapnoMAD provides innovative solutions to fight sleep apnea through two technologies: bioMAD, which optimizes airway openness, and capnoMAD, which monitors breathing patterns for personalized treatment.